MARKET NEWS

Starton Therapeutics Files PCT & US Patent Application for Continuous Delivery of Lenalidomide & Class of Immunomodulatory Agents
Proveris Scientific Announces its Laboratory Compliance With cGMP
TG Therapeutics Announces Publication of Ublituximab Phase 2 Clinical Trial Results
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
Aravive & WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies
TTP Collaborates With ODx to Develop New Technology to Address Antibiotic Resistance
FDA Approves FENSOLVI for Injectable Suspension for Pediatric Patients with Central Precocious Puberty

  FEATURED EDITORIAL

  COMPANY PROFILE

Headquartered in Nashville,TN PMI BioPharma Solutions is a team of highly experienced life science experts providing rigorous research, pharmaceutical development, and clinical manufacturing services to clients in the pharmaceutical and biotechnology space. We pride ourselves on our abilities, integrity, and persistence in the face of challenge, and will exert maximal effort and ingenuity to achieve your goals. Click here for more.


Pace Analytical Life Sciences (PLS) provides services to help improve human health. Every day our technical teams work together to ensure the safety and efficacy of treatments and therapies created by local and global manufacturers of drugs and medical devices. We share a common goal to bring real value to people, healthcare professionals, and health businesses around the world. Driven by our commitment to improve our health, we deliver services that offer hope — and a better, safer, and healthier life for everyone. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Proveris Scientific Announces Contract Test Services to Support Development of SARS-CoV-2 (COVID-19) Inhaled Drug Therapies & Vaccines

Proveris Scientific Announces Contract Test Services to Support Development of SARS-CoV-2 (COVID-19) Inhaled Drug Therapies & Vaccines

Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced the availability of contract test services to support….

 Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership With CytoDyn

 Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership With CytoDyn

Ajinomoto Bio-Pharma Services recently announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late stage biotechnology company, for the supply of the investigational new drug….

Arcturus Therapeutics & Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine

Arcturus Therapeutics & Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine

Arcturus Therapeutics Holdings Inc. and Catalent, Inc.recently announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to….

Valneva & Pfizer Announce Collaboration to Co-Develop & Commercialize Vaccine

Valneva & Pfizer Announce Collaboration to Co-Develop & Commercialize Vaccine

Valneva SE (Valneva) recently announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine candidate….

3M Drug Delivery Systems Launches as Independent Company, Kindeva Drug Delivery

3M Drug Delivery Systems Launches as Independent Company, Kindeva Drug Delivery

Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, recently announced its launch as an independent company following the acquisition by Altaris Capital Partners in a transaction valued at….

Adare Pharmaceuticals Acquires Orbis Biosciences

Adare Pharmaceuticals Acquires Orbis Biosciences

Adare Pharmaceuticals, Inc. recently announced it has acquired the pharmaceutical technology company, Orbis Biosciences, Inc. The acquisition of Orbis will….

WEBINAR - Developing an Oral Modified-Release (MR) Formulation: Challenges & Considerations for Achieving Success

WEBINAR - Developing an Oral Modified-Release (MR) Formulation: Challenges & Considerations for Achieving Success

Please join Quotient Sciences’ Vice President of Pharmaceutical Sciences, Dr. Andy Lewis, on May 20 at 10 AM London/11 AM Brussels or 6 PM London/1 PM New York for a live webinar on modified-release formulation…

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

May 20 – Particle Design Technology
May 27 – Lyophilization